Boehringer Ingelheim Taiwan Ltd yesterday awarded six research teams and pharmaceutical start-ups to support their efforts in innovation as their work shows great potential for satisfying unmet medical needs, it said.
The awards are part of its parent company’s “Grass Roots Initiative” program, which enables the study of emerging science by championing early-stage life-science companies, managing director James Chiou (邱建誌) told an award ceremony in Taipei.
The six teams were selected by the company’s headquarters out of 169 companies that applied for the reward, Chiou said.
Photo courtesy of Boehringer Ingelheim
Through the program, Boehringer Ingelheim not only encourages innovation in medicine, but also gets a chance to learn about start-ups with great potential firsthand, giving it an opportunity to partner with new companies and enhance its research and development resources, Chiou said.
One team headed by Sun Wei-lun (孫偉倫), a postdoctoral researcher at Taipei Medical University, succeeded in embedding a section of a human cancer cell on an integrated circuit chip specially made to fit the cell, she said.
When the chip is charged with electricity, the cell would react, meaning that a chip embedded with such a cell could be used to test different drugs to see which works best to treat various types of cancer, Sun said.
Photo courtesy of Boehringer Ingelheim
Although the team has not concluded whether testing a cell on the chip would work in exactly the same way as administering a drug to a cancer cell in a human body, the cell-on-chip system would be better than using immortalized cancer cells such as in conventional studies, as the chip system would provide “fresher” cells, Sun said.
Every chip could be personalized, and it takes about three days to extract a cell and place it on the chip, Sun said, adding that the chips are provided by National Tsing Hua University.
Sun’s team tested its technology in a trial in which patients with lung cancer are given specific drugs, while their cells on the chips are also given the same treatment, and the team observes whether the results are comparable, Sun said.
The innovation is likely to change medicine development, she said.
Sun plans to set up her own company and would be interested in cooperating with pharmaceutical firms, she said.
Another team led by Yang Kai-chien (楊鎧鍵), an associate professor of National Taiwan University’s pharmacology graduate institute, discovered a new treatment for fibrosis.
The team found that the TXNDC5, an endoplasmic reticulum resident protein, plays a key role in fibrotic scarring, Yang said.
Unlike pharmaceutical companies that aims to cure fibrosis by giving patients compound drugs, Yang’s team developed a DNA aptamer that can bind to TXNDC5, thus curbing the fibrosis-triggering protein’s activity, he said.
As the TXNDC5 had been found active in the development of fibrosis in many organs — pulmonary fibrosis, cardiac fibrosis and kidney fibrosis — the potential of the treatment is great, he said.
Like Sun, Yang also plans to set up his own company, he said.
Annji Pharmaceutials Co Ltd is also focusing on fibrosis treatment. It developed an experimental drug, dubbed AJ303, and aims to obtain US regulators’ approval to conduct a phase-one human trial by the end of the year, president and CEO Wendy Huang (黃文英) said.
The company chose to conduct human tests in the US to include multiethnic participants so that its drug could be used worldwide, Huang said.
“As Boehringer Ingelheim is the provider of the standard treatment for pulmonary fibrosis, we feel honored to obtain its recognition,” Huang said, adding that she hopes there would be opportunities for further collaboration.
JelloX Biotech Inc developed a 3D imaging technology for biopsies, which would help doctors see tumors better and more accurately prescribe medicine, CEO Lin Yen-yin (林彥穎) said.
“Although it was the first time that the start-up-supporting program was introduced in Taiwan, our headquarters said it was impressed with the overall quality of work made by these Taiwanese applicants,” Chiou said.
While the program only accepted work in six areas — digital health, regeneration medicine, cancer, autoimmune disease, fibrosis and gene therapy — the local unit found that among all the projects by the 169 local applicants, the ratio of work in cancer or fibrosis was comparatively high, Chiou said.
“It is understandable that many companies are focusing on cancer treatment, as cancers receive great attention worldwide, but I was a bit surprised to know that so many local companies or teams devote themselves to fibrosis treatment, as the number of patients with fibrosis is not particularly high in Taiwan,” Chiou said.
Boehringer Ingelheim Taiwan’s parent company talked with the six award-winning teams and gave them advice about business models, patent protection and sustainable development, while it is also to evaluate whether to pursue further collaboration with the start-ups, Chiou said.
The company has acquired treatment methods from local companies in the past, he added.
Boehringer Ingelheim is a research-driven company, devoted to innovative medicine and supports young life-science companies by providing mentoring, support and valuable resources to help them progress, Boehringer Ingelheim China president and CEO Felix Gutsche said in a statement.
Japanese lawmakers have been refraining from visiting China for fear of being arrested and not being able to return, while Taiwan is a popular destination, Japan’s Sankei Shimbun reported. As 120 Japanese Diet members visited Taiwan last year and fewer than 10 went to China, Beijing hopes that they could visit China more often, Japanese Ambassador to China Kenji Kanasugi was cited as saying during a meeting of Japan’s Liberal Democratic Party on Thursday last week. Kanasugi was in Japan to attend the Conference of the Ambassadors to Asian and Oceanian Countries and International Organizations, which was held on Thursday and Friday
INVASION: A UK based think tank said in a report published on Friday that Russia-China 5G collaboration could be applied in the event of a Taiwan contingency Russian-Chinese collaboration on 5G and satellite technologies could give Russia an advantage on the battlefield in Ukraine and could feasibly be applied in other theaters, including a potential Chinese invasion of Taiwan, a report by the Royal United Services Institute for Defence and Security (RUSI) published on Friday said. Russia and China have already tested the use of shared 5G technology to control uncrewed dump trucks at a Russian mine, and have tested the integration of their respective navigation systems, Russia’s GLONASS and China’s BeiDou, the report said. “In Ukraine, GLONASS has already enabled Russian missile and drone strikes via satellite correction
A Singaporean social media streamer who goes by the pseudonym Kiaraakitty faked an egg attack by an alleged passerby during a livestream in Kaohsiung on Feb. 9, the city’s police department said on Saturday. The department was responding to the streamer’s claim earlier this month that a stranger had thrown eggs at her during a recent visit to Kaohsiung. Kiaraakitty is known for posting provocative content on livestreaming sites such as Twitch and Discord, as well as other social media platforms such as Instagram, Facebook and YouTube. She also posts on paid adult content Web site OnlyFans. In the video dated Feb. 9,
HOT TOPIC: The Taiwan-born founder of a restaurant in the Japanese city is generally credited with creating the super spicy dish, which was originally intended as a staff meal For Taiwanese, ramen is one of the dishes that most represents Japan; for Japanese, its origins are in China. Then there is “Taiwan ramen,” which can only be found in Japan, but not in Taiwan. It is almost impossible to reach a consensus on the origin of any dish, but a brief look at its history might be helpful. Not many people who are not Japanese question whether ramen is really Japanese. Yet think about it — ramen is often unctuous and rich, unlike most other must-try Japanese foods familiar to foreign visitors to the country, such as sushi and soba noodles. According